SlideShare una empresa de Scribd logo
1 de 72
 The biosynthesis of a protein or a
polypeptide in a living cell is referred to as
translation.
 The sequence of amino acids in the protein
synthesized is determined by the nucleotide
base sequence of mRNA.
 The three nucleotide (triplet) base sequences
in mRNA that act as code for amino acids in
protein constitute the genetic code or codons.
 The genetic code may be regarded as a
dictionary of nucleotide bases (A, G, C & U)
that determines the sequence of amino acids
in proteins.
 The codons are composed of the 4 nucleotide
bases, purines - adenine (A) & guanine (C) &
pyrimidines – cytosine (C) & uracil (U).
 These four bases produce 64 different
combinations (43) of three base codons.
 The nucleotide sequence of the codon on
mRNA is written from the 5'-end to 3' end.
 61 codons code for the 20 amino acids.
 The three codons UAA, UAG and UGA do not
code for amino acids.
 They act as stop signals in protein synthesis.
 These three codons are collectively known as
termination codons or non-sense codons.
 The codons AUG & sometimes, GUG are the
chain initiating codons.
 Universality:
 The same codons are used to code for the
same amino acids in all the living organisms.
 Genetic code is appropriately regarded as
universal.
 Few exceptions, AUA is the codon for
methionine in mitochondria.
 The same codon (AUA) codes for isoleucine in
cytoplasm.
 Specificity:
 A particular codon always codes for the
same amino acid, hence the genetic code is
highly specific or unambiguous e.g. UGG is
the codon for tryptophan
 Non-overlapping:
 The genetic code is read from a fixed point
as a continuous base sequence.
 It is non-overlapping, commaless & without
any punctuations.
 UUUCUUAGAGGG is read as
UUU/CUU/AGA/GGG.
 Addition or deletion of one or two bases will
radically change the message sequence in
mRNA.
 And the protein synthesized from such mRNA
will be totally different.
 Degenerate:
 Most of the amino acids have more than one
codon.
 The codon is degenerate, since there are 61
codons to code for only 20 amino acids.
 E.g. glycine has four codons.
 The codons that designate the same amino
acid are called synonyms.
 Most of the synonyms differ only in the third
(3' end) base of the codon.
 The codon of the mRNA is recognized by the
anticodon of tRNA.
 They pair with each other in antiparallel
direction (5‘ - 3' of mRNA with 3' - 5' of tRNA).
 The complementary base pairing (A-U, C - G)
occurs between the first two bases of codon &
last two bases of anticodon.
 Anticodon region of tRNA recognizes codon in
mRNA.
 A single tRNA can recognize more than one
codon.
 This is due to third base (3'-base) in the codon
often fails to recognize the specific
complementary base in the anticodon (5'-
base).
 Wobbling is attributed to the difference in
the spatial arrangement of the 5'-end of the
anticodon.
 The possible pairing of 5‘- end base of
anticodon (of tRNA) with the 3'-end base of
codon (mRNA).
 Wobble hypothesis explains the degeneracy
of the genetic code, i.e. existence of multiple
codons for a single amino acid.
C – G
A – U
U – G
G – U
Conventional base pairing
Non-conventional base pairing
 The protein synthesis which involves the
translation of nucleotide base sequence of
mRNA into the language of amino acid
sequence.
 Divided into the following stages.
 Requirement of the components
 Activation of amino acids
 Protein synthesis proper
 Chaperones and protein folding
 Post-translational modifications.
 All the 20 amino acids are required.
 Protein synthesis can occur only when all the
amino acids needed for a particular protein
are available.
 lf there is a deficiency in the dietary supply
of any one of the essential amino acids, the
translation stops.
 The functionally active ribosomes are the
centres or factories for protein synthesis.
 Ribosomes are huge complex structures (70S
for prokaryotes and 80S for eukaryotes) of
proteins & ribosomal RNAs.
 Each ribosome consists of two subunits - one
big & one small.
 The functional ribosome has two sites - A site
& P site.
 Each site covers both the subunits.
 A site is for binding of aminoacyl tRNA & P
site is for binding peptidyl tRNA, during the
course of translation.
 Some authors consider A site as acceptor site
& P site as donor site.
 In case of eukaryotes, there is another site
called exit site or E site.
 Eukaryotes contain 3 sites (A, P & E).
 The ribosomes are located in the cytosomal
fraction of the cell.
 They are found in association with rough
endoplasmic reticulum (RER) to form clusters
RER-ribosomes, where the protein synthesis
occurs.
 The specific information required for the
synthesis of a given protein is present on the
mRNA.
 The DNA has passed on the genetic
information in the form of codons to mRNA
to translate into a protein sequence.
 They carry the amino acids & hand them
over to the growing peptide chain.
 The amino acid is covalently bound to tRNA
at the 3'-end.
 Each tRNA has a three nucleotide base
sequence-the anticodon, which is responsible
to recognize the codon (complementary
bases) of mRNA for protein synthesis.
 Both ATP & GTP are required.
 Some of the reactions involve the breakdown
of ATP or GTP, respectively, to AMP & GMP
with the liberation of pyrophosphate.
 Each one of these reactions consumes two
high energy phosphates (equivalent to 2 ATP).
 The process of translation involves a number
of protein factors.
 These are needed for initiation, elongation &
termination of protein synthesis.
 The protein factors are more complex in
eukaryotes compared to prokaryotes.
 Amino acids are activated & attached to
tRNAs in a two step reaction.
 A group of enzymes - namely aminoacyl
tRNA synthetases are required for this
process.
 These enzymes are highly specific for the
amino acid & the corresponding tRNA.
 The amino acid is first attached to the
enzyme utilizing ATP to form enzyme-AMP-
amino acid complex.
 The amino acid is then transferred to the 3'
end of the tRNA to form aminoacyl tRNA.
 The protein or polypeptide synthesis occurs
on the ribosomes.
 The mRNA is read in the 5' - 3' direction & the
polypeptide synthesis proceeds from N -
terminal end to C-terminal end.
 The initiation of translation in eukaryotes is
complex, involving at least 10 eukaryotic
initiation factors (eIFs) & divided into 4 steps.
1. Ribosomal dissociation.
2. Formation of 43S preinitiation complex.
3. Formation of 48S initiation complex.
4. Formation of 80S initiation complex.
 The 80S ribosome dissociates to form 40S & 60S
subunits.
 Two initiating factors namely elF-3 & elF-1A
bind to the newly formed 40S subunit &
thereby block its reassociation with 60S
subunit.
 elF-3 is anti-association factor.
 A ternary complex containing met-tRNA′ &
elF-2 bound to GTP attaches to 40S ribosomal
subunit to form 43S preinitiation complex.
 The presence of elF-3 & elF-1A stabilizes this
complex.
 The binding of mRNA to 43S preinitiation
complex results in the formation of 48S
initiation complex through the intermediate
43S initiation complex.
 elF-4F complex is formed by the association of
elF-4G, elF-4A with elF-4E.
 The elF-4F (referred to as cap binding protein)
binds to the cap of mRNA.
 Then elF-4A & elF-4B bind to mRNA & reduce its
complex structure.
 This mRNA is then transferred to 43S complex.
 For the appropriate association of 43S
preinitiation complex with mRNA, energy has
to be supplied by ATP.
 The ribosomal initiation complex scans the
mRNA for the identification of appropriate
initiation codon.
 5'-AUG is the initiation codon.
 48S initiation complex binds to 60S ribosomal
subunit to form 80S initiation complex.
 The binding involves the hydrolysis of GTP
(bound to elF-2).
 This step is facilitated by the involvement of
elF-5.
 As the 80S complex is formed, the initiation
factors bound to 48S initiation complex are
released & recycled.
 The activation of elF-2 requires elF-2B (also
called as guanine nucleotide exchange
factor) & GTP.
 The activated elF2 (i.e. bound to GTP) requires
elF-2C to form the ternary complex.
 The elF-4F, a complex formed by the assembly
of three initiation factors controls initiation &
translation process.
 elF-4E, a component of elF-4F is primarily
responsible for the recognition of mRNA cap.
 This step is the rate-limiting in translation.
 elF-2, involved in formation of 43S preinitiation
complex also controls protein biosynthesis.
 The 30S ribosomal subunit is bound to
initiation factor 3 (lF-3) & attached to ternary
complex of lF-2, formyl met-tRNA & GTP.
 IF-l also participates in the formation of
preinitiation complex.
 The recognition of initiation codon AUG is
done through Shine-Dalgarno sequence (the
recognition sequence of initiation codon is
referred to as Shine-Dalgarno sequence).
 A 50S ribosome unit is now bound with the
30S unit to produce 70S initiation complex in
prokaryotes.
 Ribosomes elongate the polypeptide chain
by a sequential addition of amino acids.
 The amino acid sequence is determined by
the order of the codons in the specific mRNA.
 Elongation, a cyclic process involving certain
elongation factors (EFs).
 Elongation factors (EFs) may be divided into
three steps.
1. Binding of aminoacyl t-RNA to A-site.
2. Peptide bond formation.
3. Translocation.
 The 80S initiation complex contains met tRNA′ in the
P-site & A-site is free.
 Another aminoacyl-tRNA is placed in the A-site.
 This requires proper codon recognition on the mRNA
& involvement of elongation factor 1a (EF-1a) &
supply of energy by GTP.
 The aminoacyl-tRNA is placed in the A-site, EF-1a &
GDP are recycled to bring another aminoacyl-tRNA.
 The enzyme peptidyltransferase catalyses the
formation of peptide bond.
 The activity of this enzyme lies on 28S RNA of 60S
ribosomal subunit.
 It is therefore the rRNA (and not protein) referred to
as ribozyme that catalyses peptide bond formation.
 Net result of peptide bond formation is the
attachment of the growing peptide chain to the tRNA
in the A-site.
 The ribosome moves to the next codon of the
mRNA (towards 3'-end).
 This process called translocation, involves the
movement of growing peptide chain from A-
site to P-site.
 Translocation requires EF-2 & GTP.
 GTP gets hydrolysed & supplies energy to
move mRNA.
 EF-2 & GTP complex recycles for translocation
 Another site namely exit site (E-site) has
been identified in eukaryotes.
 The deacylated tRNA moves into the E-site,
from where it leaves the ribosome.
 In case of prokaryotes, the elongation
factors are different & they are EF-Tu, EF-Ts (in
place of EF-1a) & EF-G (instead of EF-2).
 About six amino acids per second are
incorporated during the course of elongation
of translation in eukaryotes.
 In case of prokaryotes, as many as 20 amino
acids can be incorporated per second.
 The process of protein/polypeptide synthesis
in translation occurs with great speed &
accuracy.
 One of the stop or termination signals (UAA,
UAG and UGA) terminates the growing
polypeptide.
 The termination codons which act as stop
signals do not have specific tRNAs to bind.
 Streptomycin:
 Initiation of protein synthesis is inhibited by
streptomycin.
 It causes misreading of mRNA and interferes
with the normal pairing between codons &
anticodons.
 Tetracycline:
 It inhibits the binding of aminoacyl tRNA to
the ribosomal complex.
 Puromycin:
 This has a structural resemblance to
aminoacyl tRNA.
 Puromycin enters the A site & gets
incorporated into the growing peptide chain
and causes its release.
 This antibiotic prevents protein synthesis in
both prokaryotes & eukaryotes.
 Chloramphenicol:
 It acts as a competitive inhibitor of the enzyme
peptidyltransferase & interferes with elongation of
peptide chain.
 Erythromycin:
 It inhibits translocation by binding with 50S subunit of
bacterial ribosome.
 Diphtheria toxin:
 It prevents translocation in eukaryotic protein
synthesis by inactivating elongation factor eEF2.
 Chaperones are heat shock proteins
(discovered in response to heat shock).
 They facilitate & favour the interactions on the
polypeptide surfaces to finally give specific
conformation of a protein.
 Chaperones can reversibly bind to
hydrophobic regions of unfolded proteins &
folding intermediates.
 They can stabilize intermediates, prevent
formation of incorrect intermediates, and
also prevent undesirable interactions with
other proteins.
 All these activities of chaperones help the
protein to attain compact & biologically
active conformation.
1. Hsp70 system
2. Chaperonin system
 Hsp70 system:
 This mainly consists of Hsp70 (70-kDa heat
shock protein) & Hsp40 (40-kDa Hsp).
 These proteins can bind individually to the
substrate (protein) & help in the correct
formation of protein folding.
 Chaperonin system
 This is a large oligomeric assembly which
forms a structure into which the folded
proteins are inserted.
 The chaperonin system mainly has Hsp60 &
Hsp10. i.e. 60 kDa Hsp and 10 kDa Hsp.
 Chaperonins are required at a later part of
the protein folding process & often work in
association with Hsp70 system.
 The failure of a protein to fold properly generally
leads to its rapid degradation.
 Cystic fibrosis (CF) is a common autosomal recessive
disease.
 Some cases of CF with mutations that result in
altered protein (cystic fibrosis transmembrane
conductance regulator or in short CFTR).
 CFTR cannot fold properly, besides not being able to
get glycosylated or transported.
 CFTR gets degraded.
 Certain neurological diseases - due to cellular
accumulation of aggregates of misfolded
proteins or their partially degraded products.
 The term prions (proteinous infectious agents)
is used to collectively represent them.
 Prions exhibit the characteristics of viral or
microbial pathogens and have been implicated
in many diseases. e.g. Alzheimer's disease.
 The proteins synthesized in translation are as
such, not functional.
 Many changes take place in the polypeptides
after the protein synthesis is completed.
 These modifications include protein folding,
trimming by proteolytic degradation, intein
splicing & covalent changes, collectively known
as post-translational modifications.
 Many proteins are synthesized as the
precursors which are much bigger in size than
the functional proteins.
 Some portions of precursor molecules are
removed by proteolysis to liberate active
proteins.
 This process is referred to as trimming.
 E.g. preproinsulin, trypsinogen to active forms.
 Inteins are intervening sequences in certain
proteins.
 These are comparable to introns in mRNAs.
 lnteins have to be removed & exteins ligated
in the appropriate order for the protein to
become active.
 The proteins synthesized in translation are
subjected to many covalent changes.
 By these modifications in the amino acids,
the proteins may be converted to active form
or inactive form.
1. Phosphorylation
2. Hydroxylation
3. Glycosylation
 The hydroxyl group containing amino acids
of proteins, namely serine, threonine &
tyrosine are subjected to phosphorylation.
 The phosphorylation may either increase or
decrease the activity of the proteins.
 A group of enzymes called protein kinases.
 Protein kinases catalyses phosphorylation
while protein phosphatases are responsible
for dephosphorylation.
 Many enzymes that undergo
phosphorylation or dephosphorylation (e.g.
Glycogen synthase)
 During the formation of collagen, the amino
acids proline & lysine are respectively
converted to hydroxyproline &
hydroxylysine.
 This hydroxylation occurs in the endoplasmic
reticulum & requires vitaminC.
 The attachment of carbohydrate moiety is
essential for some proteins.
 The complex carbohydrate moiety is attached
to the amino acids, serine & threonine (O-
linked) or to asparagine (N-linked), leading to
the synthesis of glycoproteins.
 Vitamin K dependent carboxylation of
glutamic acid residues in certain clotting
factors is also a post-translational
modification.
 Textbook of Biochemistry – U Satyanarayana
 Textbook of Biochemistry – DM Vasudevan
TRANSLATION & POST - TRANSLATIONAL MODIFICATIONS

Más contenido relacionado

La actualidad más candente

Charging of tRNA, Aminoacyl tRNA Synthetases
Charging of tRNA, Aminoacyl tRNA Synthetases Charging of tRNA, Aminoacyl tRNA Synthetases
Charging of tRNA, Aminoacyl tRNA Synthetases J K COLLEGE,PURULIA
 
DNA replication
DNA replicationDNA replication
DNA replicationEmaSushan
 
Dna replication eukaryotes
Dna replication eukaryotesDna replication eukaryotes
Dna replication eukaryotesPARADHI
 
Genetic code features and character
Genetic code features and characterGenetic code features and character
Genetic code features and characterAnuKiruthika
 
Transcription process
Transcription processTranscription process
Transcription processTouheed Ovi
 
tRNA structure and function
tRNA structure and functiontRNA structure and function
tRNA structure and functionHarshita Bhawsar
 
Dna replication in eukaryotes
Dna replication in eukaryotesDna replication in eukaryotes
Dna replication in eukaryotesM Vignesh
 
Protein targeting or translocation of proteins
Protein targeting or translocation of proteinsProtein targeting or translocation of proteins
Protein targeting or translocation of proteinsHaider Ali Malik
 
5’ capping
5’ capping5’ capping
5’ cappingEmaSushan
 
Polyadenylation
PolyadenylationPolyadenylation
PolyadenylationEmaSushan
 

La actualidad más candente (20)

Charging of tRNA, Aminoacyl tRNA Synthetases
Charging of tRNA, Aminoacyl tRNA Synthetases Charging of tRNA, Aminoacyl tRNA Synthetases
Charging of tRNA, Aminoacyl tRNA Synthetases
 
DNA replication
DNA replicationDNA replication
DNA replication
 
Eukaryotic transcription
Eukaryotic transcriptionEukaryotic transcription
Eukaryotic transcription
 
Dna replication eukaryotes
Dna replication eukaryotesDna replication eukaryotes
Dna replication eukaryotes
 
Post transcriptional modification ( splicing mechanisms)
Post transcriptional modification ( splicing mechanisms)Post transcriptional modification ( splicing mechanisms)
Post transcriptional modification ( splicing mechanisms)
 
DNA Replication
 DNA Replication DNA Replication
DNA Replication
 
Genetic code
Genetic codeGenetic code
Genetic code
 
Genetic code features and character
Genetic code features and characterGenetic code features and character
Genetic code features and character
 
Translation an overview
Translation  an overviewTranslation  an overview
Translation an overview
 
Biosynthesis of purine & pyrimidine
Biosynthesis of purine & pyrimidine Biosynthesis of purine & pyrimidine
Biosynthesis of purine & pyrimidine
 
Transcription process
Transcription processTranscription process
Transcription process
 
Genetic code -
Genetic code - Genetic code -
Genetic code -
 
tRNA structure and function
tRNA structure and functiontRNA structure and function
tRNA structure and function
 
Nucleotide metabolism
Nucleotide metabolismNucleotide metabolism
Nucleotide metabolism
 
Dna replication in eukaryotes
Dna replication in eukaryotesDna replication in eukaryotes
Dna replication in eukaryotes
 
Protein targeting or translocation of proteins
Protein targeting or translocation of proteinsProtein targeting or translocation of proteins
Protein targeting or translocation of proteins
 
Protein sorting and targeting
Protein sorting and targetingProtein sorting and targeting
Protein sorting and targeting
 
5’ capping
5’ capping5’ capping
5’ capping
 
Protein synthesis
Protein synthesisProtein synthesis
Protein synthesis
 
Polyadenylation
PolyadenylationPolyadenylation
Polyadenylation
 

Destacado (7)

Protien
ProtienProtien
Protien
 
6ed68c 20110926 chapter26-outline
6ed68c 20110926   chapter26-outline6ed68c 20110926   chapter26-outline
6ed68c 20110926 chapter26-outline
 
lac operon and trp operon ppt
lac operon and trp operon pptlac operon and trp operon ppt
lac operon and trp operon ppt
 
Bacteriophage
BacteriophageBacteriophage
Bacteriophage
 
281 lec21 phage_repressor
281 lec21 phage_repressor281 lec21 phage_repressor
281 lec21 phage_repressor
 
Lac Operon
Lac OperonLac Operon
Lac Operon
 
Operon
Operon Operon
Operon
 

Similar a TRANSLATION & POST - TRANSLATIONAL MODIFICATIONS

Protein synthesis.ppt
Protein synthesis.pptProtein synthesis.ppt
Protein synthesis.pptdrpvczback
 
Translation
TranslationTranslation
TranslationNandy 91
 
Synthesis of proteins__regulation_11
Synthesis of proteins__regulation_11Synthesis of proteins__regulation_11
Synthesis of proteins__regulation_11MUBOSScz
 
Translation in prokaryotes and eukaryotes
Translation in prokaryotes and eukaryotesTranslation in prokaryotes and eukaryotes
Translation in prokaryotes and eukaryotesNaman Sharma
 
protein synthesis biochem.ppt
protein synthesis biochem.pptprotein synthesis biochem.ppt
protein synthesis biochem.pptRinaDas9
 
Translation in Prokaryotes and Eukaryotes
Translation  in Prokaryotes and Eukaryotes Translation  in Prokaryotes and Eukaryotes
Translation in Prokaryotes and Eukaryotes Ikram Ullah
 
Translation in Prokaryotes and Eukaryotes
Translation in Prokaryotes and EukaryotesTranslation in Prokaryotes and Eukaryotes
Translation in Prokaryotes and EukaryotesIkram Ullah
 
Translation: Protein synthesis
Translation: Protein synthesisTranslation: Protein synthesis
Translation: Protein synthesisDr. Mafatlal Kher
 
PROTEIN SYNTHESIS IN EUKARYOTES.pptx
PROTEIN SYNTHESIS IN EUKARYOTES.pptxPROTEIN SYNTHESIS IN EUKARYOTES.pptx
PROTEIN SYNTHESIS IN EUKARYOTES.pptxAnkitaDas188735
 
New microsoft office word document
New microsoft office word documentNew microsoft office word document
New microsoft office word documentmithu mehr
 
Translation and microbial protein production
Translation and microbial protein productionTranslation and microbial protein production
Translation and microbial protein productionmithu mehr
 
Protein synthesis(ragahv mishra)
Protein synthesis(ragahv mishra)Protein synthesis(ragahv mishra)
Protein synthesis(ragahv mishra)RaghavMishra33
 

Similar a TRANSLATION & POST - TRANSLATIONAL MODIFICATIONS (20)

Protein synthesis.ppt
Protein synthesis.pptProtein synthesis.ppt
Protein synthesis.ppt
 
5,.translation
5,.translation5,.translation
5,.translation
 
Translation sohil
Translation sohilTranslation sohil
Translation sohil
 
Translation
TranslationTranslation
Translation
 
Synthesis of proteins__regulation_11
Synthesis of proteins__regulation_11Synthesis of proteins__regulation_11
Synthesis of proteins__regulation_11
 
Translation in prokaryotes and eukaryotes
Translation in prokaryotes and eukaryotesTranslation in prokaryotes and eukaryotes
Translation in prokaryotes and eukaryotes
 
Translation
TranslationTranslation
Translation
 
Translation.pdf
Translation.pdfTranslation.pdf
Translation.pdf
 
Biomol-Translation Eukaryote.pptx
Biomol-Translation Eukaryote.pptxBiomol-Translation Eukaryote.pptx
Biomol-Translation Eukaryote.pptx
 
M Rna.Translation
M Rna.TranslationM Rna.Translation
M Rna.Translation
 
protein synthesis biochem.ppt
protein synthesis biochem.pptprotein synthesis biochem.ppt
protein synthesis biochem.ppt
 
Translation in Prokaryotes and Eukaryotes
Translation  in Prokaryotes and Eukaryotes Translation  in Prokaryotes and Eukaryotes
Translation in Prokaryotes and Eukaryotes
 
Translation in Prokaryotes and Eukaryotes
Translation in Prokaryotes and EukaryotesTranslation in Prokaryotes and Eukaryotes
Translation in Prokaryotes and Eukaryotes
 
Translation: Protein synthesis
Translation: Protein synthesisTranslation: Protein synthesis
Translation: Protein synthesis
 
Translation
TranslationTranslation
Translation
 
Gene Expression: Translation
Gene Expression: TranslationGene Expression: Translation
Gene Expression: Translation
 
PROTEIN SYNTHESIS IN EUKARYOTES.pptx
PROTEIN SYNTHESIS IN EUKARYOTES.pptxPROTEIN SYNTHESIS IN EUKARYOTES.pptx
PROTEIN SYNTHESIS IN EUKARYOTES.pptx
 
New microsoft office word document
New microsoft office word documentNew microsoft office word document
New microsoft office word document
 
Translation and microbial protein production
Translation and microbial protein productionTranslation and microbial protein production
Translation and microbial protein production
 
Protein synthesis(ragahv mishra)
Protein synthesis(ragahv mishra)Protein synthesis(ragahv mishra)
Protein synthesis(ragahv mishra)
 

Más de YESANNA

PERICARDIAL FLUID
PERICARDIAL FLUIDPERICARDIAL FLUID
PERICARDIAL FLUIDYESANNA
 
SYNOVIAL FLUID
SYNOVIAL FLUID SYNOVIAL FLUID
SYNOVIAL FLUID YESANNA
 
ASCITIC FLUID ANALYSIS
ASCITIC FLUID ANALYSISASCITIC FLUID ANALYSIS
ASCITIC FLUID ANALYSISYESANNA
 
CEREBROSPINAL FLUID (CSF)
CEREBROSPINAL FLUID (CSF)CEREBROSPINAL FLUID (CSF)
CEREBROSPINAL FLUID (CSF)YESANNA
 
Oxidative Stress in Preeclampsia
Oxidative Stress in Preeclampsia Oxidative Stress in Preeclampsia
Oxidative Stress in Preeclampsia YESANNA
 
GANDHAM RAJEEV-BIOCHEMISTRY IMPORTANT QUESTIONS-RGUHS-2017
GANDHAM RAJEEV-BIOCHEMISTRY IMPORTANT QUESTIONS-RGUHS-2017GANDHAM RAJEEV-BIOCHEMISTRY IMPORTANT QUESTIONS-RGUHS-2017
GANDHAM RAJEEV-BIOCHEMISTRY IMPORTANT QUESTIONS-RGUHS-2017YESANNA
 
MINERALS-REVISION - 27-05-2017
MINERALS-REVISION - 27-05-2017MINERALS-REVISION - 27-05-2017
MINERALS-REVISION - 27-05-2017YESANNA
 
IRON METABOLISM
IRON METABOLISMIRON METABOLISM
IRON METABOLISMYESANNA
 
METABOLISM OF ZINC, MAGNESIUM & ELECTROLYTES
METABOLISM OF ZINC, MAGNESIUM & ELECTROLYTESMETABOLISM OF ZINC, MAGNESIUM & ELECTROLYTES
METABOLISM OF ZINC, MAGNESIUM & ELECTROLYTESYESANNA
 
METABOLISM OF SULFUR, IODINE, MANGANESE,FLUORINE & SELENIUM
METABOLISM OF SULFUR, IODINE, MANGANESE,FLUORINE & SELENIUMMETABOLISM OF SULFUR, IODINE, MANGANESE,FLUORINE & SELENIUM
METABOLISM OF SULFUR, IODINE, MANGANESE,FLUORINE & SELENIUMYESANNA
 
COPPER METABOLISM
COPPER METABOLISMCOPPER METABOLISM
COPPER METABOLISMYESANNA
 
MATABOLISM OF CALCIUM & PHOSPHOROUS
MATABOLISM OF CALCIUM & PHOSPHOROUSMATABOLISM OF CALCIUM & PHOSPHOROUS
MATABOLISM OF CALCIUM & PHOSPHOROUSYESANNA
 
RIBOFLAVIN (B2)
RIBOFLAVIN (B2)RIBOFLAVIN (B2)
RIBOFLAVIN (B2)YESANNA
 
NIACIN (B3)
NIACIN (B3)NIACIN (B3)
NIACIN (B3)YESANNA
 
VITAMIN LIKE COMPOUNDS
VITAMIN LIKE COMPOUNDS VITAMIN LIKE COMPOUNDS
VITAMIN LIKE COMPOUNDS YESANNA
 
VITAMIN C
VITAMIN CVITAMIN C
VITAMIN CYESANNA
 
COBALAMINE (12)
COBALAMINE (12) COBALAMINE (12)
COBALAMINE (12) YESANNA
 
FOLIC ACID (B9)
FOLIC ACID (B9)FOLIC ACID (B9)
FOLIC ACID (B9)YESANNA
 
BIOTIN (B7)
BIOTIN (B7)BIOTIN (B7)
BIOTIN (B7)YESANNA
 
PYRIDOXINE (B6)
PYRIDOXINE (B6)PYRIDOXINE (B6)
PYRIDOXINE (B6)YESANNA
 

Más de YESANNA (20)

PERICARDIAL FLUID
PERICARDIAL FLUIDPERICARDIAL FLUID
PERICARDIAL FLUID
 
SYNOVIAL FLUID
SYNOVIAL FLUID SYNOVIAL FLUID
SYNOVIAL FLUID
 
ASCITIC FLUID ANALYSIS
ASCITIC FLUID ANALYSISASCITIC FLUID ANALYSIS
ASCITIC FLUID ANALYSIS
 
CEREBROSPINAL FLUID (CSF)
CEREBROSPINAL FLUID (CSF)CEREBROSPINAL FLUID (CSF)
CEREBROSPINAL FLUID (CSF)
 
Oxidative Stress in Preeclampsia
Oxidative Stress in Preeclampsia Oxidative Stress in Preeclampsia
Oxidative Stress in Preeclampsia
 
GANDHAM RAJEEV-BIOCHEMISTRY IMPORTANT QUESTIONS-RGUHS-2017
GANDHAM RAJEEV-BIOCHEMISTRY IMPORTANT QUESTIONS-RGUHS-2017GANDHAM RAJEEV-BIOCHEMISTRY IMPORTANT QUESTIONS-RGUHS-2017
GANDHAM RAJEEV-BIOCHEMISTRY IMPORTANT QUESTIONS-RGUHS-2017
 
MINERALS-REVISION - 27-05-2017
MINERALS-REVISION - 27-05-2017MINERALS-REVISION - 27-05-2017
MINERALS-REVISION - 27-05-2017
 
IRON METABOLISM
IRON METABOLISMIRON METABOLISM
IRON METABOLISM
 
METABOLISM OF ZINC, MAGNESIUM & ELECTROLYTES
METABOLISM OF ZINC, MAGNESIUM & ELECTROLYTESMETABOLISM OF ZINC, MAGNESIUM & ELECTROLYTES
METABOLISM OF ZINC, MAGNESIUM & ELECTROLYTES
 
METABOLISM OF SULFUR, IODINE, MANGANESE,FLUORINE & SELENIUM
METABOLISM OF SULFUR, IODINE, MANGANESE,FLUORINE & SELENIUMMETABOLISM OF SULFUR, IODINE, MANGANESE,FLUORINE & SELENIUM
METABOLISM OF SULFUR, IODINE, MANGANESE,FLUORINE & SELENIUM
 
COPPER METABOLISM
COPPER METABOLISMCOPPER METABOLISM
COPPER METABOLISM
 
MATABOLISM OF CALCIUM & PHOSPHOROUS
MATABOLISM OF CALCIUM & PHOSPHOROUSMATABOLISM OF CALCIUM & PHOSPHOROUS
MATABOLISM OF CALCIUM & PHOSPHOROUS
 
RIBOFLAVIN (B2)
RIBOFLAVIN (B2)RIBOFLAVIN (B2)
RIBOFLAVIN (B2)
 
NIACIN (B3)
NIACIN (B3)NIACIN (B3)
NIACIN (B3)
 
VITAMIN LIKE COMPOUNDS
VITAMIN LIKE COMPOUNDS VITAMIN LIKE COMPOUNDS
VITAMIN LIKE COMPOUNDS
 
VITAMIN C
VITAMIN CVITAMIN C
VITAMIN C
 
COBALAMINE (12)
COBALAMINE (12) COBALAMINE (12)
COBALAMINE (12)
 
FOLIC ACID (B9)
FOLIC ACID (B9)FOLIC ACID (B9)
FOLIC ACID (B9)
 
BIOTIN (B7)
BIOTIN (B7)BIOTIN (B7)
BIOTIN (B7)
 
PYRIDOXINE (B6)
PYRIDOXINE (B6)PYRIDOXINE (B6)
PYRIDOXINE (B6)
 

Último

Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 

Último (20)

Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 

TRANSLATION & POST - TRANSLATIONAL MODIFICATIONS

  • 1.
  • 2.  The biosynthesis of a protein or a polypeptide in a living cell is referred to as translation.  The sequence of amino acids in the protein synthesized is determined by the nucleotide base sequence of mRNA.
  • 3.  The three nucleotide (triplet) base sequences in mRNA that act as code for amino acids in protein constitute the genetic code or codons.  The genetic code may be regarded as a dictionary of nucleotide bases (A, G, C & U) that determines the sequence of amino acids in proteins.
  • 4.  The codons are composed of the 4 nucleotide bases, purines - adenine (A) & guanine (C) & pyrimidines – cytosine (C) & uracil (U).  These four bases produce 64 different combinations (43) of three base codons.  The nucleotide sequence of the codon on mRNA is written from the 5'-end to 3' end.  61 codons code for the 20 amino acids.
  • 5.
  • 6.  The three codons UAA, UAG and UGA do not code for amino acids.  They act as stop signals in protein synthesis.  These three codons are collectively known as termination codons or non-sense codons.  The codons AUG & sometimes, GUG are the chain initiating codons.
  • 7.  Universality:  The same codons are used to code for the same amino acids in all the living organisms.  Genetic code is appropriately regarded as universal.  Few exceptions, AUA is the codon for methionine in mitochondria.  The same codon (AUA) codes for isoleucine in cytoplasm.
  • 8.  Specificity:  A particular codon always codes for the same amino acid, hence the genetic code is highly specific or unambiguous e.g. UGG is the codon for tryptophan  Non-overlapping:  The genetic code is read from a fixed point as a continuous base sequence.  It is non-overlapping, commaless & without any punctuations.
  • 9.  UUUCUUAGAGGG is read as UUU/CUU/AGA/GGG.  Addition or deletion of one or two bases will radically change the message sequence in mRNA.  And the protein synthesized from such mRNA will be totally different.  Degenerate:  Most of the amino acids have more than one codon.
  • 10.  The codon is degenerate, since there are 61 codons to code for only 20 amino acids.  E.g. glycine has four codons.  The codons that designate the same amino acid are called synonyms.  Most of the synonyms differ only in the third (3' end) base of the codon.
  • 11.  The codon of the mRNA is recognized by the anticodon of tRNA.  They pair with each other in antiparallel direction (5‘ - 3' of mRNA with 3' - 5' of tRNA).  The complementary base pairing (A-U, C - G) occurs between the first two bases of codon & last two bases of anticodon.  Anticodon region of tRNA recognizes codon in mRNA.
  • 12.
  • 13.  A single tRNA can recognize more than one codon.  This is due to third base (3'-base) in the codon often fails to recognize the specific complementary base in the anticodon (5'- base).
  • 14.  Wobbling is attributed to the difference in the spatial arrangement of the 5'-end of the anticodon.  The possible pairing of 5‘- end base of anticodon (of tRNA) with the 3'-end base of codon (mRNA).
  • 15.  Wobble hypothesis explains the degeneracy of the genetic code, i.e. existence of multiple codons for a single amino acid. C – G A – U U – G G – U Conventional base pairing Non-conventional base pairing
  • 16.  The protein synthesis which involves the translation of nucleotide base sequence of mRNA into the language of amino acid sequence.
  • 17.  Divided into the following stages.  Requirement of the components  Activation of amino acids  Protein synthesis proper  Chaperones and protein folding  Post-translational modifications.
  • 18.  All the 20 amino acids are required.  Protein synthesis can occur only when all the amino acids needed for a particular protein are available.  lf there is a deficiency in the dietary supply of any one of the essential amino acids, the translation stops.
  • 19.  The functionally active ribosomes are the centres or factories for protein synthesis.  Ribosomes are huge complex structures (70S for prokaryotes and 80S for eukaryotes) of proteins & ribosomal RNAs.  Each ribosome consists of two subunits - one big & one small.
  • 20.  The functional ribosome has two sites - A site & P site.  Each site covers both the subunits.  A site is for binding of aminoacyl tRNA & P site is for binding peptidyl tRNA, during the course of translation.  Some authors consider A site as acceptor site & P site as donor site.
  • 21.  In case of eukaryotes, there is another site called exit site or E site.  Eukaryotes contain 3 sites (A, P & E).  The ribosomes are located in the cytosomal fraction of the cell.  They are found in association with rough endoplasmic reticulum (RER) to form clusters RER-ribosomes, where the protein synthesis occurs.
  • 22.  The specific information required for the synthesis of a given protein is present on the mRNA.  The DNA has passed on the genetic information in the form of codons to mRNA to translate into a protein sequence.
  • 23.  They carry the amino acids & hand them over to the growing peptide chain.  The amino acid is covalently bound to tRNA at the 3'-end.  Each tRNA has a three nucleotide base sequence-the anticodon, which is responsible to recognize the codon (complementary bases) of mRNA for protein synthesis.
  • 24.  Both ATP & GTP are required.  Some of the reactions involve the breakdown of ATP or GTP, respectively, to AMP & GMP with the liberation of pyrophosphate.  Each one of these reactions consumes two high energy phosphates (equivalent to 2 ATP).
  • 25.  The process of translation involves a number of protein factors.  These are needed for initiation, elongation & termination of protein synthesis.  The protein factors are more complex in eukaryotes compared to prokaryotes.
  • 26.  Amino acids are activated & attached to tRNAs in a two step reaction.  A group of enzymes - namely aminoacyl tRNA synthetases are required for this process.  These enzymes are highly specific for the amino acid & the corresponding tRNA.
  • 27.  The amino acid is first attached to the enzyme utilizing ATP to form enzyme-AMP- amino acid complex.  The amino acid is then transferred to the 3' end of the tRNA to form aminoacyl tRNA.
  • 28.
  • 29.  The protein or polypeptide synthesis occurs on the ribosomes.  The mRNA is read in the 5' - 3' direction & the polypeptide synthesis proceeds from N - terminal end to C-terminal end.
  • 30.  The initiation of translation in eukaryotes is complex, involving at least 10 eukaryotic initiation factors (eIFs) & divided into 4 steps. 1. Ribosomal dissociation. 2. Formation of 43S preinitiation complex. 3. Formation of 48S initiation complex. 4. Formation of 80S initiation complex.
  • 31.  The 80S ribosome dissociates to form 40S & 60S subunits.  Two initiating factors namely elF-3 & elF-1A bind to the newly formed 40S subunit & thereby block its reassociation with 60S subunit.  elF-3 is anti-association factor.
  • 32.  A ternary complex containing met-tRNA′ & elF-2 bound to GTP attaches to 40S ribosomal subunit to form 43S preinitiation complex.  The presence of elF-3 & elF-1A stabilizes this complex.
  • 33.  The binding of mRNA to 43S preinitiation complex results in the formation of 48S initiation complex through the intermediate 43S initiation complex.  elF-4F complex is formed by the association of elF-4G, elF-4A with elF-4E.  The elF-4F (referred to as cap binding protein) binds to the cap of mRNA.
  • 34.  Then elF-4A & elF-4B bind to mRNA & reduce its complex structure.  This mRNA is then transferred to 43S complex.  For the appropriate association of 43S preinitiation complex with mRNA, energy has to be supplied by ATP.
  • 35.  The ribosomal initiation complex scans the mRNA for the identification of appropriate initiation codon.  5'-AUG is the initiation codon.
  • 36.  48S initiation complex binds to 60S ribosomal subunit to form 80S initiation complex.  The binding involves the hydrolysis of GTP (bound to elF-2).  This step is facilitated by the involvement of elF-5.
  • 37.  As the 80S complex is formed, the initiation factors bound to 48S initiation complex are released & recycled.  The activation of elF-2 requires elF-2B (also called as guanine nucleotide exchange factor) & GTP.  The activated elF2 (i.e. bound to GTP) requires elF-2C to form the ternary complex.
  • 38.
  • 39.  The elF-4F, a complex formed by the assembly of three initiation factors controls initiation & translation process.  elF-4E, a component of elF-4F is primarily responsible for the recognition of mRNA cap.  This step is the rate-limiting in translation.  elF-2, involved in formation of 43S preinitiation complex also controls protein biosynthesis.
  • 40.  The 30S ribosomal subunit is bound to initiation factor 3 (lF-3) & attached to ternary complex of lF-2, formyl met-tRNA & GTP.  IF-l also participates in the formation of preinitiation complex.
  • 41.  The recognition of initiation codon AUG is done through Shine-Dalgarno sequence (the recognition sequence of initiation codon is referred to as Shine-Dalgarno sequence).  A 50S ribosome unit is now bound with the 30S unit to produce 70S initiation complex in prokaryotes.
  • 42.  Ribosomes elongate the polypeptide chain by a sequential addition of amino acids.  The amino acid sequence is determined by the order of the codons in the specific mRNA.  Elongation, a cyclic process involving certain elongation factors (EFs).
  • 43.  Elongation factors (EFs) may be divided into three steps. 1. Binding of aminoacyl t-RNA to A-site. 2. Peptide bond formation. 3. Translocation.
  • 44.  The 80S initiation complex contains met tRNA′ in the P-site & A-site is free.  Another aminoacyl-tRNA is placed in the A-site.  This requires proper codon recognition on the mRNA & involvement of elongation factor 1a (EF-1a) & supply of energy by GTP.  The aminoacyl-tRNA is placed in the A-site, EF-1a & GDP are recycled to bring another aminoacyl-tRNA.
  • 45.  The enzyme peptidyltransferase catalyses the formation of peptide bond.  The activity of this enzyme lies on 28S RNA of 60S ribosomal subunit.  It is therefore the rRNA (and not protein) referred to as ribozyme that catalyses peptide bond formation.  Net result of peptide bond formation is the attachment of the growing peptide chain to the tRNA in the A-site.
  • 46.
  • 47.  The ribosome moves to the next codon of the mRNA (towards 3'-end).  This process called translocation, involves the movement of growing peptide chain from A- site to P-site.  Translocation requires EF-2 & GTP.  GTP gets hydrolysed & supplies energy to move mRNA.  EF-2 & GTP complex recycles for translocation
  • 48.  Another site namely exit site (E-site) has been identified in eukaryotes.  The deacylated tRNA moves into the E-site, from where it leaves the ribosome.  In case of prokaryotes, the elongation factors are different & they are EF-Tu, EF-Ts (in place of EF-1a) & EF-G (instead of EF-2).
  • 49.  About six amino acids per second are incorporated during the course of elongation of translation in eukaryotes.  In case of prokaryotes, as many as 20 amino acids can be incorporated per second.  The process of protein/polypeptide synthesis in translation occurs with great speed & accuracy.
  • 50.  One of the stop or termination signals (UAA, UAG and UGA) terminates the growing polypeptide.  The termination codons which act as stop signals do not have specific tRNAs to bind.
  • 51.
  • 52.  Streptomycin:  Initiation of protein synthesis is inhibited by streptomycin.  It causes misreading of mRNA and interferes with the normal pairing between codons & anticodons.  Tetracycline:  It inhibits the binding of aminoacyl tRNA to the ribosomal complex.
  • 53.  Puromycin:  This has a structural resemblance to aminoacyl tRNA.  Puromycin enters the A site & gets incorporated into the growing peptide chain and causes its release.  This antibiotic prevents protein synthesis in both prokaryotes & eukaryotes.
  • 54.  Chloramphenicol:  It acts as a competitive inhibitor of the enzyme peptidyltransferase & interferes with elongation of peptide chain.  Erythromycin:  It inhibits translocation by binding with 50S subunit of bacterial ribosome.  Diphtheria toxin:  It prevents translocation in eukaryotic protein synthesis by inactivating elongation factor eEF2.
  • 55.  Chaperones are heat shock proteins (discovered in response to heat shock).  They facilitate & favour the interactions on the polypeptide surfaces to finally give specific conformation of a protein.  Chaperones can reversibly bind to hydrophobic regions of unfolded proteins & folding intermediates.
  • 56.  They can stabilize intermediates, prevent formation of incorrect intermediates, and also prevent undesirable interactions with other proteins.  All these activities of chaperones help the protein to attain compact & biologically active conformation.
  • 57. 1. Hsp70 system 2. Chaperonin system  Hsp70 system:  This mainly consists of Hsp70 (70-kDa heat shock protein) & Hsp40 (40-kDa Hsp).  These proteins can bind individually to the substrate (protein) & help in the correct formation of protein folding.
  • 58.  Chaperonin system  This is a large oligomeric assembly which forms a structure into which the folded proteins are inserted.  The chaperonin system mainly has Hsp60 & Hsp10. i.e. 60 kDa Hsp and 10 kDa Hsp.  Chaperonins are required at a later part of the protein folding process & often work in association with Hsp70 system.
  • 59.  The failure of a protein to fold properly generally leads to its rapid degradation.  Cystic fibrosis (CF) is a common autosomal recessive disease.  Some cases of CF with mutations that result in altered protein (cystic fibrosis transmembrane conductance regulator or in short CFTR).  CFTR cannot fold properly, besides not being able to get glycosylated or transported.  CFTR gets degraded.
  • 60.  Certain neurological diseases - due to cellular accumulation of aggregates of misfolded proteins or their partially degraded products.  The term prions (proteinous infectious agents) is used to collectively represent them.  Prions exhibit the characteristics of viral or microbial pathogens and have been implicated in many diseases. e.g. Alzheimer's disease.
  • 61.  The proteins synthesized in translation are as such, not functional.  Many changes take place in the polypeptides after the protein synthesis is completed.  These modifications include protein folding, trimming by proteolytic degradation, intein splicing & covalent changes, collectively known as post-translational modifications.
  • 62.
  • 63.  Many proteins are synthesized as the precursors which are much bigger in size than the functional proteins.  Some portions of precursor molecules are removed by proteolysis to liberate active proteins.  This process is referred to as trimming.  E.g. preproinsulin, trypsinogen to active forms.
  • 64.  Inteins are intervening sequences in certain proteins.  These are comparable to introns in mRNAs.  lnteins have to be removed & exteins ligated in the appropriate order for the protein to become active.
  • 65.  The proteins synthesized in translation are subjected to many covalent changes.  By these modifications in the amino acids, the proteins may be converted to active form or inactive form. 1. Phosphorylation 2. Hydroxylation 3. Glycosylation
  • 66.  The hydroxyl group containing amino acids of proteins, namely serine, threonine & tyrosine are subjected to phosphorylation.  The phosphorylation may either increase or decrease the activity of the proteins.  A group of enzymes called protein kinases.
  • 67.  Protein kinases catalyses phosphorylation while protein phosphatases are responsible for dephosphorylation.  Many enzymes that undergo phosphorylation or dephosphorylation (e.g. Glycogen synthase)
  • 68.  During the formation of collagen, the amino acids proline & lysine are respectively converted to hydroxyproline & hydroxylysine.  This hydroxylation occurs in the endoplasmic reticulum & requires vitaminC.
  • 69.  The attachment of carbohydrate moiety is essential for some proteins.  The complex carbohydrate moiety is attached to the amino acids, serine & threonine (O- linked) or to asparagine (N-linked), leading to the synthesis of glycoproteins.
  • 70.  Vitamin K dependent carboxylation of glutamic acid residues in certain clotting factors is also a post-translational modification.
  • 71.  Textbook of Biochemistry – U Satyanarayana  Textbook of Biochemistry – DM Vasudevan